Clinical Trials on Refractory Acute Myelogenous Leukemia in New Zealand
Total 1008 results
-
Dana-Farber Cancer InstituteKaryopharm Therapeutics Inc; William Lawrence and Blanche Hughes FoundationActive, not recruitingRelapsed Acute Lymphoblastic Leukemia (ALL) | Refractory Acute Lymphoblastic Leukemia (ALL) | Relapsed Acute Myelogenous Leukemia (AML) | Refractory Acute Myelogenous Leukemia (AML) | Relapsed Mixed Lineage Leukemia | Refractory Mixed Lineage Leukemia | Relapsed Biphenotypic Leukemia | Refractory... and other conditionsUnited States
-
Eisai Inc.TerminatedPediatric Acute Myelogenous Leukemia (AML)United States, Canada, Australia
-
Novartis PharmaceuticalsCompletedAcute Myelogenous Leukemia | Refractory LeukemiaBelgium, Korea, Republic of, Turkey, Germany, Australia, France, Switzerland, United Kingdom, Spain, Italy, Peru, United States
-
University of RochesterCompletedAcute Myelogenous LeukemiaUnited States
-
Eisai Inc.Withdrawn
-
SGX Pharmaceuticals, Inc.TerminatedAcute Myelogenous LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingHIV Infection | Hematopoietic and Lymphoid Cell Neoplasm | Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Erythroid Leukemia | Acute Megakaryoblastic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Chronic Myelogenous Leukemia, BCR-ABL1... and other conditionsUnited States
-
PfizerNo longer availableCD33 Positive Acute Myelogenous LeukemiaUnited States
-
University of KentuckyNational Institutes of Health (NIH)CompletedAcute Myelogenous LeukemiaUnited States
-
Kinex Pharmaceuticals Inc.CompletedAcute Myelogenous LeukemiaUnited States
-
Maxinovel Pty., Ltd.RecruitingAcute Myelogenous Leukemia (AML)Australia
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedAcute Myelogenous LeukemiaUnited States
-
Aptose Biosciences Inc.TerminatedAcute Myelogenous Leukemia | Acute Myelogenous Leukemia in Relapse | Acute Myelogenous Leukemia, Relapsed, Adult | Acute Myelogenous Leukemia, Adult | High Risk MyelodysplasiaUnited States
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI)CompletedLeukemiaUnited States
-
AbbVieGenentech, Inc.CompletedAML | Acute Myelogenous LeukemiaUnited States, Australia, Germany, Italy
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)Completed
-
Hybrigenics CorporationUnknownAcute Myelogenous LeukemiaUnited States, France
-
Actinium PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia | Leukemia, Myeloid, Acute | AML | Acute Myelogenous Leukemia | Bone Marrow Transplant | Myelogenous Leukemia, Acute | Myeloid Leukemia, Acute | Leukemia, Acute Myelogenous | Leukemia, Acute MyeloidUnited States, Canada
-
Eleos, Inc.CompletedAcute Myelogenous LeukemiaUnited States
-
Ascenta TherapeuticsThe Leukemia and Lymphoma SocietyTerminated
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic... and other conditionsUnited States, Canada, New Zealand
-
Genzyme, a Sanofi CompanyCompletedAcute Myelogenous LeukemiaUnited States, France, Germany, Canada, Italy
-
Genzyme, a Sanofi CompanyCompletedAcute Myeloid Leukemia | Acute Myelogenous LeukemiaUnited States
-
Hoffmann-La RocheCompletedMyelogenous Leukemia, AcuteCanada, United States, United Kingdom, France, Italy
-
CelgeneApproved for marketing
-
Genzyme, a Sanofi CompanyCompletedAcute Myelogenous LeukemiaUnited States
-
Merus N.V.Active, not recruitingAcute Myeloid Leukemia | Acute Myelogenous LeukemiaUnited States, Italy, Netherlands, Belgium, France
-
Calithera Biosciences, IncTerminatedAcute Myelogenous LeukemiaUnited States, Canada
-
Genzyme, a Sanofi CompanyCompletedLeukemia, Myelocytic, Acute, PediatricUnited States
-
Hackensack Meridian HealthTerminatedMyeloproliferative Disorders | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myeloid MalignanciesUnited States
-
AbbVieGenentech, Inc.TerminatedAcute Myelogenous Leukemia | Myelogenous Leukemia | Treatment Naive AMLUnited States, Australia, France, Germany
-
Hoffmann-La RocheCompletedMyelogenous Leukemia, AcuteUnited States, Korea, Republic of, Australia, United Kingdom, Canada, France, Italy
-
Northwell HealthNew York Blood CenterCompletedHodgkin Lymphoma | Acute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-Hodgkin's Lymphoma | Myelodysplastic Syndromes (MDS) | Acute Lymphoblastic Leukemia (ALL) | Myeloproliferative Disorder | Acute Myelogenous Leukemia (AML) | Chronic Myelogenous Leukemia (CML)United States
-
Kyowa Kirin, Inc.TerminatedMyelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMyelodysplastic Syndromes (MDS) | Acute Myelogenous Leukemia (AML)United States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)Completed
-
New York Medical CollegeGenzyme, a Sanofi CompanyCompletedAcute Lymphoblastic Leukemia | Acute Myelogenous LeukemiaUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumGateway for Cancer ResearchCompletedLymphoblastic Leukemia, Acute, Childhood | Myelogenous Leukemia, Acute, ChildhoodUnited States, Canada, Australia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Myelofibrosis | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Refractory Chronic Myelomonocytic Leukemia | High Risk... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia Refractory | Relapsed Acute Myeloid LeukemiaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Puerto Rico, South Africa
-
Seagen Inc.CompletedAcute Myeloid Leukemia | Acute Myelogenous Leukemia | Acute Promyelocytic LeukemiaUnited States
-
Aptose Biosciences Inc.RecruitingRelapsed or Refractory Acute Myeloid LeukemiaUnited States, Germany, Spain, Korea, Republic of, Australia, New Zealand
-
Therapeutic Advances in Childhood Leukemia ConsortiumTerminatedRelapsed Acute Lymphoblastic Leukemia | Relapsed Acute Myelogenous LeukemiaUnited States
-
Weill Medical College of Cornell UniversityJazz PharmaceuticalsCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
ViaCellCompletedAcute Myeloid Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Nohla Therapeutics, Inc.National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedMyelodysplastic Syndrome | Chronic Myelogenous Leukemia | Acute Biphenotypic Leukemia | Acute Myeloid Leukemia in Remission | Acute Lymphoblastic Leukemia in RemissionUnited States
-
OncoTherapy Science, Inc.TerminatedAML | Advanced MDS | ALL | Advanced CML | Advanced MPNsUnited States
-
Facet BiotechNational Cancer Institute (NCI)UnknownLeukemiaUnited States, Canada, Netherlands, Belgium, Germany, United Kingdom, France